Bio-Techne Corporation
NasdaqGS:TECH
Sector
Location
Market Cap
USD 9.05 B
Share Price
USD 57.71
Avg Daily Volume
2,391,101
Change (1 day)
-0.28%
Change (1 year)
-29.60%
Change (YTD)
-19.88%
Bio-Techne Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD 264.85 M
Bio-Techne Corporation Operating Cash Flow is USD 264.85 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -13.70% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Bio-Techne Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 306.88 M, a 12.12% change year over year.
-
Bio-Techne Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 273.72 M, a -20.56% change year over year.
-
Bio-Techne Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 344.57 M, a 25.33% change year over year.
-
Bio-Techne Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 274.94 M, a 27.07% change year over year.
StockViz
Competitors
Danaher Corporation
USD 203.99
DHR
-2.86
-1.38%
Agilent Technologies, Inc.
USD 118.05
A
-1.79
-1.49%
Inner Mongolia Baotou Steel Union Co., Ltd.
USD 0.39
600010.SS
-0.02
-5.09%
Qiagen N.V.
USD 50.57
QGEN
-0.50
-0.98%
Bruker Corporation
USD 40.90
BRKR
-1.15
-2.75%
Tecan Group AG
USD 200.38
TECN.SW
-4.81
-2.34%
Beijing Hotgen Biotech Co., Ltd.
USD 27.95
688068.SS
+1.55
5.89%
Sansure Biotech Inc.
USD 3.11
688289.SS
+0.02
0.68%
Eckert & Ziegler Strahlen- und Medizintechnik AG
USD 76.40
EUZ.DE
-1.94
-2.48%
Guangzhou Wondfo Biotech Co.,Ltd
USD 3.38
300482.SZ
+0.03
0.97%
Roche Holding AG
USD 337.03
RO.SW
-3.75
-1.10%
Abbott Laboratories
USD 128.55
ABT
+0.54
0.42%
Thermo Fisher Scientific Inc.
USD 477.28
TMO
-4.88
-1.01%
Boston Scientific Corporation
USD 106.76
BSX
+0.29
0.27%
Chugai Pharmaceutical Co., Ltd.
USD 49.79
4519.T
+0.26
0.52%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Danaher Corporation
USD 203.99
DHR
-2.86
-1.38%
Agilent Technologies, Inc.
USD 118.05
A
-1.79
-1.49%
Inner Mongolia Baotou Steel Union Co., Ltd.
USD 0.39
600010.SS
-0.02
-5.09%
Qiagen N.V.
USD 50.57
QGEN
-0.50
-0.98%
Bruker Corporation
USD 40.90
BRKR
-1.15
-2.75%
Tecan Group AG
USD 200.38
TECN.SW
-4.81
-2.34%
Beijing Hotgen Biotech Co., Ltd.
USD 27.95
688068.SS
+1.55
5.89%
Sansure Biotech Inc.
USD 3.11
688289.SS
+0.02
0.68%
Eckert & Ziegler Strahlen- und Medizintechnik AG
USD 76.40
EUZ.DE
-1.94
-2.48%
Guangzhou Wondfo Biotech Co.,Ltd
USD 3.38
300482.SZ
+0.03
0.97%
Roche Holding AG
USD 337.03
RO.SW
-3.75
-1.10%
Abbott Laboratories
USD 128.55
ABT
+0.54
0.42%
Thermo Fisher Scientific Inc.
USD 477.28
TMO
-4.88
-1.01%
Boston Scientific Corporation
USD 106.76
BSX
+0.29
0.27%
Chugai Pharmaceutical Co., Ltd.
USD 49.79
4519.T
+0.26
0.52%